EBP921

· Eiger BioPharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EBP921, covering 2016-08-08 to 2016-08-08. Get the full timeline:

Most recent: Clinical Trial Update: Proof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV) [Phase 1]